Global Positron Emission Tomography Market 2024-2028

The positron emission tomography market is forecasted to grow by USD 725.97 mn during 2023-2028, accelerating at a CAGR of 5.97% during the forecast period. The report on the positron emission tomography market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic conditions worldwide, the rising number of new product launches by prominent vendors, and the growing number of M&A activities.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.53%
CAGR	5.97%
Incremental Value	$725.97mn

Technavio's positron emission tomography market is segmented as below:

By Type

PET-CT
PET-MRI

By Application

Oncology
Cardiology
Neurology

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements in pet scanners as one of the prime reasons driving the positron emission tomography market growth during the next few years. Also, emergence of digital health players and innovations in radiopharmaceuticals will lead to sizable demand in the market.

The report on the positron emission tomography market covers the following areas:

Positron emission tomography market sizing
Positron emission tomography market forecast
Positron emission tomography market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading positron emission tomography market vendors that include Bracco Spa, Canon Inc., Cardinal Health Inc., CellSight Technologies Inc., CMR Naviscan Corp., GE Healthcare Technologies Inc., Jubilant Pharmova Ltd., Koninklijke Philips N.V., Mediso Ltd., MinFound Medical Systems Co. Ltd., Modus Medical Devices Inc., Neusoft Corp., Novartis AG, PETsys Electronics SA, Positron Corp., Radiology Oncology Systems Inc., RefleXion Medical Inc., Shimadzu Corp., Siemens Healthineers AG, and Yangzhou Kindsway Biotech Co. Ltd.. Also, the positron emission tomography market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR76958

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global positron emission tomography market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global positron emission tomography market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 PET-CT - Market size and forecast 2023-2028
Exhibit 34: Chart on PET-CT - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on PET-CT - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on PET-CT - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on PET-CT - Year-over-year growth 2023-2028 (%)
6.4 PET-MRI - Market size and forecast 2023-2028
Exhibit 38: Chart on PET-MRI - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on PET-MRI - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on PET-MRI - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on PET-MRI - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 44: Chart on Application - Market share 2023-2028 (%)
Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Oncology - Market size and forecast 2023-2028
Exhibit 48: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.4 Cardiology - Market size and forecast 2023-2028
Exhibit 52: Chart on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
7.5 Neurology - Market size and forecast 2023-2028
Exhibit 56: Chart on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Application
Exhibit 60: Market opportunity by Application ($ million)
Exhibit 61: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Canon Inc.
Exhibit 111: Canon Inc. - Overview
Exhibit 112: Canon Inc. - Business segments
Exhibit 113: Canon Inc. - Key news
Exhibit 114: Canon Inc. - Key offerings
Exhibit 115: Canon Inc. - Segment focus
12.4 Cardinal Health Inc.
Exhibit 116: Cardinal Health Inc. - Overview
Exhibit 117: Cardinal Health Inc. - Business segments
Exhibit 118: Cardinal Health Inc. - Key news
Exhibit 119: Cardinal Health Inc. - Key offerings
Exhibit 120: Cardinal Health Inc. - Segment focus
12.5 CellSight Technologies Inc.
Exhibit 121: CellSight Technologies Inc. - Overview
Exhibit 122: CellSight Technologies Inc. - Product / Service
Exhibit 123: CellSight Technologies Inc. - Key offerings
12.6 GE Healthcare Technologies Inc.
Exhibit 124: GE Healthcare Technologies Inc. - Overview
Exhibit 125: GE Healthcare Technologies Inc. - Business segments
Exhibit 126: GE Healthcare Technologies Inc. - Key offerings
Exhibit 127: GE Healthcare Technologies Inc. - Segment focus
12.7 Jubilant Pharmova Ltd.
Exhibit 128: Jubilant Pharmova Ltd. - Overview
Exhibit 129: Jubilant Pharmova Ltd. - Business segments
Exhibit 130: Jubilant Pharmova Ltd. - Key news
Exhibit 131: Jubilant Pharmova Ltd. - Key offerings
Exhibit 132: Jubilant Pharmova Ltd. - Segment focus
12.8 Koninklijke Philips N.V.
Exhibit 133: Koninklijke Philips N.V. - Overview
Exhibit 134: Koninklijke Philips N.V. - Business segments
Exhibit 135: Koninklijke Philips N.V. - Key news
Exhibit 136: Koninklijke Philips N.V. - Key offerings
Exhibit 137: Koninklijke Philips N.V. - Segment focus
12.9 Mediso Ltd.
Exhibit 138: Mediso Ltd. - Overview
Exhibit 139: Mediso Ltd. - Product / Service
Exhibit 140: Mediso Ltd. - Key offerings
12.10 Modus Medical Devices Inc.
Exhibit 141: Modus Medical Devices Inc. - Overview
Exhibit 142: Modus Medical Devices Inc. - Product / Service
Exhibit 143: Modus Medical Devices Inc. - Key offerings
12.11 Neusoft Corp.
Exhibit 144: Neusoft Corp. - Overview
Exhibit 145: Neusoft Corp. - Product / Service
Exhibit 146: Neusoft Corp. - Key offerings
12.12 PETsys Electronics SA
Exhibit 147: PETsys Electronics SA - Overview
Exhibit 148: PETsys Electronics SA - Product / Service
Exhibit 149: PETsys Electronics SA - Key offerings
12.13 Positron Corp.
Exhibit 150: Positron Corp. - Overview
Exhibit 151: Positron Corp. - Product / Service
Exhibit 152: Positron Corp. - Key offerings
12.14 RefleXion Medical Inc.
Exhibit 153: RefleXion Medical Inc. - Overview
Exhibit 154: RefleXion Medical Inc. - Product / Service
Exhibit 155: RefleXion Medical Inc. - Key offerings
12.15 Shimadzu Corp.
Exhibit 156: Shimadzu Corp. - Overview
Exhibit 157: Shimadzu Corp. - Business segments
Exhibit 158: Shimadzu Corp. - Key news
Exhibit 159: Shimadzu Corp. - Key offerings
Exhibit 160: Shimadzu Corp. - Segment focus
12.16 Siemens Healthineers AG
Exhibit 161: Siemens Healthineers AG - Overview
Exhibit 162: Siemens Healthineers AG - Business segments
Exhibit 163: Siemens Healthineers AG - Key news
Exhibit 164: Siemens Healthineers AG - Key offerings
Exhibit 165: Siemens Healthineers AG - Segment focus
12.17 Yangzhou Kindsway Biotech Co. Ltd.
Exhibit 166: Yangzhou Kindsway Biotech Co. Ltd. - Overview
Exhibit 167: Yangzhou Kindsway Biotech Co. Ltd. - Product / Service
Exhibit 168: Yangzhou Kindsway Biotech Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations